Prothrombin Complex Concentrates for Bleeding in the Perioperative Setting

Anesthesia and Analgesia

Volumn 122, Issue 5, 2016, Pages 1287-1300

  Ghadimi, Kamrouz ^a   Levy, Jerrold H ^a   Welsby, Ian J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; HEMOSTATIC AGENT; PROTHROMBIN COMPLEX CONCENTRATES;

BLEEDING; BRAIN HEMORRHAGE; CARDIOPULMONARY BYPASS; DRUG MECHANISM; GENERAL SURGERY; HEART SURGERY; HUMAN; LIVER INJURY; LIVER TRANSPLANTATION; OFF LABEL DRUG USE; POINT OF CARE TESTING; PRIORITY JOURNAL; REVIEW; THROMBOEMBOLISM; ADVERSE EFFECTS; ALGORITHM; ANIMAL; BLOOD; BLOOD CLOTTING; BLOOD LOSS, SURGICAL; CHEMICALLY INDUCED; CLINICAL PROTOCOL; DRUG EFFECTS; MEDICINAL CHEMISTRY; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PROCEDURES; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

ALGORITHMS; ANIMALS; ANTICOAGULANTS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; BLOOD LOSS, SURGICAL; CHEMISTRY, PHARMACEUTICAL; CLINICAL PROTOCOLS; HEMOSTATICS; HUMANS; OFF-LABEL USE; PERIOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; RISK FACTORS; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 84961221288     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000001188     Document Type: Review

References (123)

1. Sørensen B, Spahn DR, Innerhofer P, Spannagl M, Rossaint R, Clinical review: prothrombin complex concentrates-evaluation of safety and thrombogenicity. Crit Care 2011 15 201
2. Key NS, Negrier C, Coagulation factor concentrates: past, present, and future. Lancet 2007 370 439 48
3. Negrier C, Gomperts E, Oldenburg J, The history of FEIBA: a lifetime of success in the treatment of haemophilia complicated by an inhibitor. Haemophilia 2006 12 4 13
4. Lin Y, Stanworth S, Birchall J, Doree C, Hyde C, Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev 2011;3 CD005011
5. Simpson E, Lin Y, Stanworth S, Birchall J, Doree C, Hyde C, Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev 2012 3 CD005011
6. Xi M, Béguin S, Hemker HC, The relative importance of the factors II, VII, IX and X for the prothrombinase activity in plasma of orally anticoagulated patients. Thromb Haemost 1989 62 788 91
7. Imberti D, Barillari G, Biasioli C, Bianchi M, Contino L, Duce R, D'Incà M, Gnani MC, Mari E, Ageno W, Emergency reversal of anticoagulation with a three-factor prothrombin complex concentrate in patients with intracranial haemorrhage. Blood Transfus 2011 9 148 55
8. Choi Q, Kim JE, Hyun J, Han KS, Kim HK, Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays. Thromb Res 2013 132 e70 5
9. Holland L, Warkentin TE, Refaai M, Crowther MA, Johnston MA, Sarode R, Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose. Transfusion 2009 49 1171 7
10. Dzik WS, Reversal of drug-induced anticoagulation: old solutions and new problems. Transfusion 2012 52 suppl 1 45S 55S
11. Sarode R, Milling TJ Jr, Refaai MA, Mangione A, Schneider A, Durn BL, Goldstein JN, Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. Circulation 2013 128 1234 43
12. Tanaka KA, Szlam F, Dickneite G, Levy JH, Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation. Thromb Res 2008 122 117 23
13. Allen GA, Wolberg AS, Oliver JA, Hoffman M, Roberts HR, Monroe DM, Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system. J Thromb Haemost 2004 2 402 13
14. Thompson CA, Kyle R, Gertz M, Heit J, Pruthi R, Pardanani A, Systemic AL amyloidosis with acquired factor X deficiency: a study of perioperative bleeding risk and treatment outcomes in 60 patients. Am J Hematol 2010 85 171 3
15. Monroe DM, Hoffman M, Roberts HR, Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 2002 22 1381 9
16. Kumar R, Béguin S, Hemker HC, The influence of fibrinogen and fibrin on thrombin generation-evidence for feedback activation of the clotting system by clot bound thrombin. Thromb Haemost 1994 72 713 21
17. Roberts HR, Hoffman M, Monroe DM, A cell-based model of thrombin generation. Semin Thromb Hemost 2006 32 suppl 1 32 8
18. Levy JH, Szlam F, Tanaka KA, Sniecienski RM, Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding. Anesth Analg 2012 114 261 74
19. Hiippala ST, Myllylä GJ, Vahtera EM, Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995 81 360 5
20. Ranucci M, Baryshnikova E, Crapelli GB, Rahe-Meyer N, Menicanti L, Frigiola A, Surgical Clinical Outcome REsearch (SCORE) Group Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery. J Am Heart Assoc 2015 4 e002066
21. Karkouti K, Beattie WS, Arellano R, Aye T, Bussieres JS, Callum JL, Cheng D, Heinrich L, Kent B, Lee TW, MacAdams C, Mazer CD, Muirhead B, Rochon AG, Rubens FD, Sawchuk C, Wang S, Waters T, Wong BI, Yau TM, Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery. Circulation 2008 118 331 8
22. Lee AI, Campigotto F, Rawn JD, Neuberg D, Kaufman RM, Berliner N, Clinical significance of coagulation studies in predicting response to activated recombinant factor VII in cardiac surgery patients. Br J Haematol 2012 157 397 400
23. Hemker HC, Al Dieri R, De Smedt E, Béguin S, Thrombin generation, a function test of the haemostatic-thrombotic system. Thromb Haemost 2006 96 553 61
24. Hemker HC, Giesen P, AlDieri R, Regnault V, de Smed E, Wagenvoord R, Lecompte T, Béguin S, The calibrated automated thrombogram (CAT): a universal routine test for hyper-and hypocoagulability. Pathophysiol Haemost Thromb 2002 32 249 53
25. Machlus KR, Colby EA, Wu JR, Koch GG, Key NS, Wolberg AS, Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram. Thromb Haemost 2009 102 936 44
26. Dargaud Y, Béguin S, Lienhart A, Al Dieri R, Trzeciak C, Bordet JC, Hemker HC, Negrier C, Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B. Thromb Haemost 2005 93 475 80
27. Al Dieri R, Peyvandi F, Santagostino E, Giansily M, Mannucci PM, Schved JF, Béguin S, Hemker HC, The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding. Thromb Haemost 2002 88 576 82
28. Bosch Y, Al Dieri R, ten Cate H, Nelemans P, Bloemen S, Hemker C, Weerwind P, Maessen J, Mochtar B, Preoperative thrombin generation is predictive for the risk of blood loss after cardiac surgery: a research article. J Cardiothorac Surg 2013 8 154
29. Guzzetta NA, Szlam F, Kiser AS, Fernandez JD, Szlam AD, Leong T, Tanaka KA, Augmentation of thrombin generation in neonates undergoing cardiopulmonary bypass. Br J Anaesth 2014 112 319 27
30. Kaspereit F, Hoffmann S, Pragst I, Dickneite G, Prothrombin complex concentrate mitigates diffuse bleeding after cardiopulmonary bypass in a porcine model. Br J Anaesth 2010 105 576 82
31. Ay C, Dunkler D, Simanek R, Thaler J, Koder S, Marosi C, Zielinski C, Pabinger I, Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis Study. J Clin Oncol 2011 29 2099 103
32. Hron G, Kollars M, Binder BR, Eichinger S, Kyrle PA, Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. JAMA 2006 296 397 402
33. Lutsey PL, Folsom AR, Heckbert SR, Cushman M, Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) study. J Thromb Haemost 2009 7 1639 48
34. Gatt A, Riddell A, van Veen JJ, Kitchen S, Tuddenham EG, Makris M, Optimizing warfarin reversal-an ex vivo study. J Thromb Haemost 2009 7 1123 7
35. Levy JH, Tanaka KA, Dietrich W, Perioperative hemostatic management of patients treated with vitamin K antagonists. Anesthesiology 2008 109 918 26
36. Pernod G, Godiér A, Gozalo C, Tremey B, Sié P, French National Authority for Health French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding). Thromb Res 2010 126 e167 74
37. Karkouti K, McCluskey SA, Syed S, Pazaratz C, Poonawala H, Crowther MA, The influence of perioperative coagulation status on postoperative blood loss in complex cardiac surgery: a prospective observational study. Anesth Analg 2010 110 1533 40
38. Sniecinski R, Szlam F, Chen EP, Bader SO, Levy JH, Tanaka KA, Antithrombin deficiency increases thrombin activity after prolonged cardiopulmonary bypass. Anesth Analg 2008 106 713 8
39. Coakley M, Hall JE, Evans C, Duff E, Billing V, Yang L, McPherson D, Stephens E, Macartney N, Wilkes AR, Collins PW, Assessment of thrombin generation measured before and after cardiopulmonary bypass surgery and its association with postoperative bleeding. J Thromb Haemost 2011 9 282 92
40. Russo C, Girelli D, Olivieri O, Guarini P, Manzato F, Pizzolo F, Zaia B, Mazzucco A, Corrocher R, G20210A prothrombin gene polymorphism and prothrombin activity in subjects with or without angiographically documented coronary artery disease. Circulation 2001 103 2436 40
41. Faraoni D, Fenger-Eriksen C, Gillard S, Willems A, Levy JH, Van der Linden P, Evaluation of dynamic parameters of thrombus formation measured on whole blood using rotational thromboelastometry in children undergoing cardiac surgery: a descriptive study. Paediatr Anaesth 2015 25 573 9
42. Baglin TP, Keeling DM, Watson HG, British Committee for Standards in Haematology Guidelines on oral anticoagulation (warfarin): third edition-2005 update. Br J Haematol 2006 132 277 85
43. Baker RI, Coughlin PB, Gallus AS, Harper PL, Salem HH, Wood EM, Warfarin Reversal Consensus Group Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. Med J Aust 2004 181 492 7
44. Ferraris VA, Brown JR, Despotis GJ, Hammon JW, Reece TB, Saha SP, Song HK, Clough ER, Shore-Lesserson LJ, Goodnough LT, Mazer CD, Shander A, Stafford-Smith M, Waters J, Baker RA, Dickinson TA, FitzGerald DJ, Likosky DS, Shann KG, 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 2011 91 944 82
45. Holbrook A, Schulman S, Witt DM, Vandvik PO, Fish J, Kovacs MJ, Svensson PJ, Veenstra DL, Crowther M, Guyatt GH, American College of Chest Physicians Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012 141 e152S 84S
46. Leissinger CA, Blatt PM, Hoots WK, Ewenstein B, Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature. Am J Hematol 2008 83 137 43
47. Spahn DR, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernández-Mondéjar E, Filipescu D, Hunt BJ, Komadina R, Nardi G, Neugebauer E, Ozier Y, Riddez L, Schultz A, Vincent JL, Rossaint R, Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care 2013 17 R76
48. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G, American College of Chest Physicians Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008 133 160S 98S
49. Morgenstern LB, Hemphill JC III, Anderson C, Becker K, Broderick JP, Connolly ES Jr, Greenberg SM, Huang JN, MacDonald RL, Messé SR, Mitchell PH, Selim M, Tamargo RJ, American Heart Association Stroke Council and Council on Cardiovascular Nursing Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2010 41 2108 29
50. Dzik WH, Blajchman MA, Fergusson D, Hameed M, Henry B, Kirkpatrick AW, Korogyi T, Logsetty S, Skeate RC, Stanworth S, MacAdams C, Muirhead B, Clinical review: Canadian National Advisory Committee on Blood and Blood Products-Massive transfusion consensus conference 2011: report of the panel. Crit Care 2011 15 242 54
51. Steiner T, Kaste M, Forsting M, Mendelow D, Kwiecinski H, Szikora I, Juvela S, Marchel A, Chapot R, Cognard C, Unterberg A, Hacke W, Recommendations for the management of intracranial haemorrhage-part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis 2006 22 294 316
52. American Society of Anesthesiologists Task Force on Perioperative Blood Management Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management∗. Anesthesiology 2015 122 241 75
53. Görlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J, First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology 2011 115 1179 91
54. Franchini M, Lippi G, Prothrombin complex concentrates: an update. Blood Transfus 2010 8 149 54
55. Lankiewicz MW, Hays J, Friedman KD, Tinkoff G, Blatt PM, Urgent reversal of warfarin with prothrombin complex concentrate. J Thromb Haemost 2006 4 967 70
56. Pabinger I, Tiede A, Kalina U, Knaub S, Germann R, Ostermann H, Beriplex P/N Anticoagulation Reversal Study Group Impact of infusion speed on the safety and effectiveness of prothrombin complex concentrate: a prospective clinical trial of emergency anticoagulation reversal. Ann Hematol 2010 89 309 16
57. Yanamadala V, Walcott BP, Fecci PE, Rozman P, Kumar JI, Nahed BV, Swearingen B, Reversal of warfarin associated coagulopathy with 4-factor prothrombin complex concentrate in traumatic brain injury and intracranial hemorrhage. J Clin Neurosci 2014 21 1881 4
58. Demeyere R, Gillardin S, Arnout J, Strengers PF, Comparison of fresh frozen plasma and prothrombin complex concentrate for the reversal of oral anticoagulants in patients undergoing cardiopulmonary bypass surgery: a randomized study. Vox Sang 2010 99 251 60
59. Meehan R, Tavares M, Sweeney J, Clinical experience with oral versus intravenous vitamin K for warfarin reversal. Transfusion 2013 53 491 8
60. Turecek PL, Váradi K, Gritsch H, Schwarz HP, FEIBA: mode of action. Haemophilia 2004 10 suppl 2 3 9
61. Wójcik C, Schymik ML, Cure EG, Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy. Int J Emerg Med 2009 2 217 25
62. Levi M, Levy JH, Andersen HF, Truloff D, Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med 2010 363 1791 800
63. Mathijssen NC, Masereeuw R, Holme PA, van Kraaij MG, Laros-van Gorkom BA, Peyvandi F, van Heerde WL, Increased volume of distribution for recombinant activated factor VII and longer plasma-derived factor VII half-life may explain their long lasting prophylactic effect. Thromb Res 2013 132 256 62
64. Andersen ND, Bhattacharya SD, Williams JB, Fosbol EL, Lockhart EL, Patel MB, Gaca JG, Welsby IJ, Hughes GC, Intraoperative use of low-dose recombinant activated factor VII during thoracic aortic operations. Ann Thorac Surg 2012 93 1921 8
65. Hacquard M, Durand M, Lecompte T, Boini S, Briançon S, Carteaux JP, Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005-7). Eur J Cardiothorac Surg 2011 40 1320 7
66. Gill R, Herbertson M, Vuylsteke A, Olsen PS, von Heymann C, Mythen M, Sellke F, Booth F, Schmidt TA, Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. Circulation 2009 120 21 7
67. Gelsomino S, Lorusso R, Romagnoli S, Bevilacqua S, De Cicco G, Billè G, Stefàno P, Gensini GF, Treatment of refractory bleeding after cardiac operations with low-dose recombinant activated factor VII (NovoSeven): a propensity score analysis. Eur J Cardiothorac Surg 2008 33 64 71
68. Mariani G, Bernardi F, Factor VII deficiency. Semin Thromb Hemost 2009 35 400 6
69. Lee GC, Kicza AM, Liu KY, Nyman CB, Kaufman RM, Body SC, Does rotational thromboelastometry (ROTEM) improve prediction of bleeding after cardiac surgery? Anesth Analg 2012 115 499 506
70. Tanaka KA, Mazzeffi MA, Grube M, Ogawa S, Chen EP, Three-factor prothrombin complex concentrate and hemostasis after high-risk cardiovascular surgery. Transfusion 2013 53 920 1
71. Arnékian V, Camous J, Fattal S, Rézaiguia-Delclaux S, Nottin R, Stéphan F, Use of prothrombin complex concentrate for excessive bleeding after cardiac surgery. Interact Cardiovasc Thorac Surg 2012 15 382 9
72. Bolliger D, Görlinger K, Tanaka KA, Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology 2010 113 1205 19
73. Weber CF, Görlinger K, Meininger D, Herrmann E, Bingold T, Moritz A, Cohn LH, Zacharowski K, Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012 117 531 47
74. Solomon C, Hagl C, Rahe-Meyer N, Time course of haemostatic effects of fibrinogen concentrate administration in aortic surgery. Br J Anaesth 2013 110 947 56
75. Paparella D, Brister SJ, Buchanan MR, Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Med 2004 30 1873 81
76. Levy JH, Tanaka KA, Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 2003 75 S715 20
77. Bruce D, Nokes TJ, Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospital. Crit Care 2008 12 R105
78. Ortmann E, Besser MW, Sharples LD, Gerrard C, Berman M, Jenkins DP, Klein AA, An exploratory cohort study comparing prothrombin complex concentrate and fresh frozen plasma for the treatment of coagulopathy after complex cardiac surgery. Anesth Analg 2015 121 26 33
79. Whiting D, DiNardo JA, TEG and ROTEM: technology and clinical applications. Am J Hematol 2014 89 228 32
80. Ganter MT, Hofer CK, Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 2008 106 1366 75
81. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E, A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999 340 409 17
82. Karkouti K, Wijeysundera DN, Yau TM, Beattie WS, Abdelnaem E, McCluskey SA, Ghannam M, Yeo E, Djaiani G, Karski J, The independent association of massive blood loss with mortality in cardiac surgery. Transfusion 2004 44 1453 62
83. Malone DL, Dunne J, Tracy JK, Putnam AT, Scalea TM, Napolitano LM, Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma 2003 54 898 905
84. Marik PE, Corwin HL, Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med 2008 36 2667 74
85. Vamvakas EC, Blajchman MA, Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 2009 113 3406 17
86. Song HK, Tibayan FA, Kahl EA, Sera VA, Slater MS, Deloughery TG, Scanlan MM, Safety and efficacy of prothrombin complex concentrates for the treatment of coagulopathy after cardiac surgery. J Thorac Cardiovasc Surg 2014 147 1036 40
87. Williams JB, Phillips-Bute B, Bhattacharya SD, Shah AA, Andersen ND, Altintas B, Lima B, Smith PK, Hughes GC, Welsby IJ, Predictors of massive transfusion with thoracic aortic procedures involving deep hypothermic circulatory arrest. J Thorac Cardiovasc Surg 2011 141 1283 8
88. Girdauskas E, Kempfert J, Kuntze T, Borger MA, Enders J, Fassl J, Falk V, Mohr FW, Thromboelastometrically guided transfusion protocol during aortic surgery with circulatory arrest: a prospective, randomized trial. J Thorac Cardiovasc Surg 2010 140 1117 24.e2
89. Schick KS, Fertmann JM, Jauch KW, Hoffmann JN, Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding. Crit Care 2009 13 R191
90. Stuklis RG, O'Shaughnessy DF, Ohri SK, Novel approach to bleeding in patients undergoing cardiac surgery with liver dysfunction. Eur J Cardiothorac Surg 2001 19 219 20
91. Grottke O, Braunschweig T, Spronk HM, Esch S, Rieg AD, van Oerle R, ten Cate H, Fitzner C, Tolba R, Rossaint R, Increasing concentrations of prothrombin complex concentrate induce disseminated intravascular coagulation in a pig model of coagulopathy with blunt liver injury. Blood 2011 118 1943 51
92. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M, Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH) Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001 86 1327 30
93. Arshad F, Ickx B, van Beem RT, Polak W, Grüne F, Nevens F, Ilmakunnas M, Koivusalo AM, Isoniemi H, Strengers PF, Groen H, Hendriks HG, Lisman T, Pirenne J, Porte RJ, Prothrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation: PROTON-trial. BMC Surg 2013 13 22
94. Dickneite G, Pragst I, Prothrombin complex concentrate vs fresh frozen plasma for reversal of dilutional coagulopathy in a porcine trauma model. Br J Anaesth 2009 102 345 54
95. Porta CR, Nelson D, McVay D, Salgar S, Eckert M, Izenberg S, Martin MJ, The effects of tranexamic acid and prothrombin complex concentrate on the coagulopathy of trauma: an in vitro analysis of the impact of severe acidosis. J Trauma Acute Care Surg 2013 75 954 60
96. Joseph B, Amini A, Friese RS, Houdek M, Hays D, Kulvatunyou N, Wynne J, O'Keeffe T, Latifi R, Rhee P, Factor IX complex for the correction of traumatic coagulopathy. J Trauma Acute Care Surg 2012 72 828 34
97. Schöchl H, Forster L, Woidke R, Solomon C, Voelckel W, Use of rotation thromboelastometry (ROTEM) to achieve successful treatment of polytrauma with fibrinogen concentrate and prothrombin complex concentrate. Anaesthesia 2010 65 199 203
98. Schöchl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, Kozek-Langenecker S, Solomon C, Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010 14 R55
99. Schöchl H, Schlimp CJ, Trauma bleeding management: the concept of goal-directed primary care. Anesth Analg 2014 119 1064 73
100. Tanaka KA, Bolliger D, Vadlamudi R, Nimmo A, Rotational thromboelastometry (ROTEM)-based coagulation management in cardiac surgery and major trauma. J Cardiothorac Vasc Anesth 2012 26 1083 93
101. Kerebel D, Joly LM, Honnart D, Schmidt J, Galanaud D, Negrier C, Kursten F, Coriat P, Lex206 Investigator Group A French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversal. Crit Care 2013 17 R4
102. Aledort LM, Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity. J Thromb Haemost 2004 2 1700 8
103. Al-Shahi Salman R, Haemostatic drug therapies for acute spontaneous intracerebral haemorrhage. Cochrane Database Syst Rev 2009 4 CD005951
104. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T, FAST Trial Investigators Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008 358 2127 37
105. O'Connell KA, Wood JJ, Wise RP, Lozier JN, Braun MM, Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA 2006 295 293 8
106. Diringer MN, Skolnick BE, Mayer SA, Steiner T, Davis SM, Brun NC, Broderick JP, Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial. Stroke 2010 41 48 53
107. Preston FE, Laidlaw ST, Sampson B, Kitchen S, Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients. Br J Haematol 2002 116 619 24
108. Goldhammer JE, Bakowitz MJ, Milas BL, Patel PA, Intracardiac thrombosis after emergent prothrombin complex concentrate administration for warfarin reversal. Anesthesiology 2015 123 458
109. Voils SA, Baird B, Systematic review: 3-factor versus 4-factor prothrombin complex concentrate for warfarin reversal: does it matter? Thromb Res 2012 130 833 40
110. Babilonia K, Trujillo T, The role of prothrombin complex concentrates in reversal of target specific anticoagulants. Thromb J 2014 12 8
111. Levy JH, Spyropoulos AC, Samama CM, Douketis J, Direct oral anticoagulants: new drugs and new concepts. JACC Cardiovasc Interv 2014 7 1333 51
112. Levi M, Moore KT, Castillejos CF, Kubitza D, Berkowitz SD, Goldhaber SZ, Raghoebar M, Patel MR, Weitz JI, Levy JH, Comparison of three-factor and four-factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers. J Thromb Haemost 2014 12 1428 36
113. Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M, Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation 2011 124 1573 9
114. Solbeck S, Meyer MA, Johansson PI, Meyer AS, Cotton BA, Stensballe J, Schött U, Ostrowski SR, Monitoring of dabigatran anticoagulation and its reversal in vitro by thrombelastography. Int J Cardiol 2014 176 794 9
115. Schulman S, Ritchie B, Goy JK, Nahirniak S, Almutawa M, Ghanny S, Activated prothrombin complex concentrate for dabigatran-associated bleeding. Br J Haematol 2014 164 308 10
116. Grottke O, van Ryn J, Spronk HM, Rossaint R, Prothrombin complex concentrates and a specific antidote to dabigatran are effective ex-vivo in reversing the effects of dabigatran in an anticoagulation/liver trauma experimental model. Crit Care 2014 18 R27
117. Glund S, Moschetti V, Norris S, Stangier J, Schmohl M, van Ryn J, Lang B, Ramael S, Reilly P, A randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran. Thromb Haemost 2015 113 943 51
118. Siegal DM, Curnutte JT, Connolly SJ, Lu G, Conley PB, Wiens BL, Mathur VS, Castillo J, Bronson MD, Leeds JM, Mar FA, Gold A, Crowther MA, Andexanet Alfa for the reversal of factor Xa inhibitor activity. N Engl J Med 2015 373 2413 24
119. Ghadimi K, Dombrowski KE, Levy JH, Welsby IJ, Andexanet Alfa for the reversal of factor Xa inhibitor related anticoagulation. Expert Rev Hematol 2016 9 115 22
120. Dolgin E, Antidotes progress for new oral clotbusters. Nat Biotechnol 2015 33 117 8
121. Enriquez A, Lip GY, Baranchuk A, Anticoagulation reversal in the era of the non-vitamin K oral anticoagulants. Europace 2015. [ePub ahead of print]
122. Schiele F, van Ryn J, Canada K, Newsome C, Sepulveda E, Park J, Nar H, Litzenburger T, A specific antidote for dabigatran: functional and structural characterization. Blood 2013 121 3554 62
123. Pollack CV Jr, Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kamphuisen PW, Kreuzer J, Levy JH, Sellke FW, Stangier J, Steiner T, Wang B, Kam CW, Weitz JI, Idarucizumab for dabigatran reversal. N Engl J Med 2015 373 511 20